Get the Stockscreener App
86.73
3.12%
2.625
After Hours:
86.74
0.005
+0.01%
Iradimed Corp stock is traded at $86.73, with a volume of 230.79K.
It is up +3.12% in the last 24 hours and up +21.75% over the past month.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
See More
Previous Close:
$84.11
Open:
$84.11
24h Volume:
230.79K
Relative Volume:
3.84
Market Cap:
$1.10B
Revenue:
$69.48M
Net Income/Loss:
$18.64M
P/E Ratio:
59.41
EPS:
1.46
Net Cash Flow:
$13.01M
1W Performance:
+8.70%
1M Performance:
+21.75%
6M Performance:
+62.21%
1Y Performance:
+75.72%
1-Day Range:
$80.55
$87.88
1-Week Range:
$75.75
$87.88
52-Week Range:
$47.48
$87.88
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
86.73 | 1.07B | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
Iradimed Corp’s Earnings Call Highlights Record Growth and Optimism - TipRanks
iRadimed Corporation Announces Quarterly Dividend of $0.17 (NASDAQ:IRMD) - MarketBeat
iRadimed (NASDAQ:IRMD) Shares Gap Up Following Analyst Upgrade - MarketBeat
iRadimed (NASDAQ:IRMD) Posts Earnings Results, Meets Expectations - MarketBeat
Iradimed stock hits all-time high of 84.99 USD - Investing.com
iRadimed (NASDAQ:IRMD) Issues Q4 2025 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Updates FY 2025 Earnings Guidance - MarketBeat
IRadimed Corporation (NASDAQ:IRMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Analyzing recovery setups for IRADIMED CORPORATION investorsIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
AlphaQuest LLC Reduces Holdings in iRadimed Corporation $IRMD - MarketBeat
What to expect from IRADIMED CORPORATION in the next 30 daysPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
iRadimed (NASDAQ:IRMD) Hits New 52-Week High Following Dividend Announcement - MarketBeat
Iradimed Corp Reports Record Q3 2025 Results - TipRanks
Will IRADIMED CORPORATION stock deliver consistent dividendsDollar Strength & Weekly Top Performers Watchlists - newser.com
IRadimed: Q3 Earnings Snapshot - Chron
Earnings call transcript: Iradimed Co Q3 2025 beats EPS estimates, stock surges - Investing.com
IRadimed Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Iradimed Lifts Forecasts As Q3 Results Top Expectations - Finimize
IRadimed Corp. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance - Markets Mojo
Is now a turning point for IRADIMED CORPORATIONGlobal Markets & Daily Technical Forecast Reports - newser.com
IRMD Forecasts FY25 Revenue Between $82.5M and $83.5M - GuruFocus
IRMD Achieves Record Q3 Revenue Growth, Overcoming Transitional Challenges - GuruFocus
IRMD Projects Q4 Revenue to Range Between $21.4M and $22.4M - GuruFocus
IRadimed’s Record Quarter Lands On Wall Street’s Buy List - Finimize
Iradimed Corporation Reports Record Q3 2025 Revenue of $21.2 Million and Raises Full-Year Guidance - Quiver Quantitative
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results - TradingView
Ranking IRADIMED CORPORATION among high performing stocks via toolsQuarterly Earnings Report & Real-Time Volume Trigger Notifications - newser.com
Teacher Retirement System of Texas Sells 11,152 Shares of iRadimed Corporation $IRMD - MarketBeat
What recovery options are there for IRADIMED CORPORATIONCEO Change & Daily Entry Point Alerts - newser.com
Using R and stats models for IRADIMED CORPORATION forecastingWeekly Trade Recap & High Return Trade Opportunity Guides - newser.com
Will IRADIMED CORPORATION (46K) stock beat growth indexesTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-02 11:55:05 - newser.com
Leading vs lagging indicators on IRADIMED CORPORATION performanceJuly 2025 Summary & Daily Stock Trend Reports - newser.com
iRadimed (NASDAQ:IRMD) Given Buy Rating at Roth Capital - MarketBeat
iRadimed (NASDAQ:IRMD) Raised to “Strong-Buy” at Roth Capital - Defense World
iRadimed (IRMD) Expected to Announce Earnings on Monday - Defense World
iRadimed's (IRMD) Buy (B) Rating Reaffirmed at Weiss Ratings - MarketBeat
Historical volatility pattern of IRADIMED CORPORATION visualizedQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
iRadimed Corp (IRMD) Q3 2025 Earnings Report Preview: What to Look For - Yahoo Finance
iRadimed Corp (IRMD) Q3 2025 Earnings Report Preview: What to Lo - GuruFocus
Can IRADIMED CORPORATION stock sustain revenue growthQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
iRadimed (IRMD) Coverage Resumed with Positive Outlook by Roth C - GuruFocus
iRadimed (NASDAQ:IRMD) CEO Sells $388,450.00 in Stock - MarketBeat
iRadimed (NASDAQ:IRMD) Sets New 12-Month HighShould You Buy? - MarketBeat
IRADIMED Earnings Preview: Recent $IRMD Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
IRadimed Corp. Hits New 52-Week High of $79.14, Up 84.64% - Markets Mojo
Developing predictive dashboards with IRADIMED CORPORATION data2025 Sector Review & Low Risk High Win Rate Picks - newser.com
IRadimed Corp. Experiences Evaluation Revision Amid Strong Market Performance and Dynamics - Markets Mojo
How supply shortages influence IRADIMED CORPORATION (46K) stockJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Can IRADIMED CORPORATION stock deliver surprise earnings beatTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Iradimed Corporation to Release 2025 Third Quarter Financial Results on November 3, 2025 - Quiver Quantitative
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):